Early research (Phase 1)Ended earlyNCT03360006
What this trial is testing
A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 30